News in the Life Sciences Industry

LUND, Sweden, April 2, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announce that new preclinical data on the drug candidate ATOR-1144 will be presented at the scientific conference AACR (American Association for Cancer Research), held in Atlanta on March... Read more ››

BERGEN, Norway, April 2, 2019 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO) a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces preclinical data strengthening bemcentinib's broad potential in reversing tumour-mediated... Read more ››

BERGEN, Norway, April 2, 2019 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO) announces that the first patient has been dosed in an additional cohort ("Cohort B") of an ongoing Phase II open-label study of BerGenBio's selective AXL inhibitor bemcentinib in combination with Merck's anti-PD-1 therapy... Read more ››

COPENHAGEN, Denmark, April 1, 2019 /PRNewswire/ -- IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies, based on its proprietary T-win® technology, presented preclinical data on the therapeutic potential of an immunomodulatory CCL22-based... Read more ››

STOCKHOLM, April 1, 2019 /PRNewswire/ --

STOCKHOLM, April 1, 2019 /PRNewswire/ -- On February 12th, 2019, it was announced that Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") has entered into agreement with RoundTable Healthcare Partners and Signet Healthcare Partners to divest the entire commercial operation and that... Read more ››

UPPSALA, Sweden, April 1, 2019 /PRNewswire/ -- Biotage's 2018 Annual Report and Corporate Governance Report are as of today available at: www.biotage.com.... Read more ››